Literature DB >> 33893137

Febrile neutropenia due to COVID-19 in an immunocompetent patient.

Yumkham Monica Devi1, Amit Sehrawat2, Prasan Kumar Panda3, Uttam Kumar Nath2.   

Abstract

While lymphopenia has been a common finding in COVID-19 infection, particularly in severe cases, febrile neutropenia has been very rarely reported in immunocompetent patients with COVID-19. Herein, we report the case of a 76-year-old hypertensive and diabetic man who was hospitalised with severe COVID-19 infection and developed delayed-onset severe neutropenia with neutropenic fever, which responded to treatment with antibiotics and granulocyte colony-stimulating factor. This case highlights the importance of identifying a rare complication (febrile neutropenia on the fifth week) of COVID-19 infection in hospitalised patients by intensive monitoring and aggressive management for favourable outcomes. © BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  COVID-19; adult intensive care; haematology (drugs and medicines); infectious diseases

Year:  2021        PMID: 33893137     DOI: 10.1136/bcr-2021-242683

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

1.  Self-limiting severe neutropenia in a patient with COVID-19.

Authors:  Ram Singh; Brajesh Kumar Ratre; Prashant Sirohiya; Sushma Bhatnagar
Journal:  BMJ Case Rep       Date:  2021-11-30

2.  Ethnicity-Specific Features of COVID-19 Among Arabs, Africans, South Asians, East Asians, and Caucasians in the United Arab Emirates.

Authors:  Fatmah Al Zahmi; Tetiana Habuza; Rasha Awawdeh; Hossam Elshekhali; Martin Lee; Nassim Salamin; Ruhina Sajid; Dhanya Kiran; Sanjay Nihalani; Darya Smetanina; Tatsiana Talako; Klaus Neidl-Van Gorkom; Nazar Zaki; Tom Loney; Yauhen Statsenko
Journal:  Front Cell Infect Microbiol       Date:  2022-03-16       Impact factor: 5.293

3.  Coexistence of Pancytopenia and Myositis After Developing COVID-19.

Authors:  Tatsuhiko Okayasu; Ryuichi Ohta; Mari Igarashi; Yasuo Kurita; Miho Hayakawa; Chiaki Sano
Journal:  Cureus       Date:  2022-07-18

4.  Tree Shrew Is a Suitable Animal Model for the Study of Epstein Barr Virus.

Authors:  Wei Xia; Honglin Chen; Yiwei Feng; Nan Shi; Zongjian Huang; Qingyuan Feng; Xu Jiang; Guangyao He; Mao Xie; Yongjin Lai; Zhi Wang; Xiang Yi; Anzhou Tang
Journal:  Front Immunol       Date:  2022-01-17       Impact factor: 7.561

Review 5.  COVID 19 and febrile neutropenia: Case report and systematic review.

Authors:  Taner Kaya; Ahmet Dilek; Resat Ozaras; Ozlem Sahin Balcik; Hakan Leblebicioglu
Journal:  Travel Med Infect Dis       Date:  2022-03-07       Impact factor: 20.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.